Obiettivo
Our objective is to create within the Community the ditions for emergence of novel therapeutic approaches to neurodegenerative disease and neurotrauma, which represent an urgent socio-eomic and human need. The NeuroNE sortium (22 academic groups, 6 SMEs and 1 management partner in 9 different countries) will take a multi-disciplinary (functional genomics and proteomics, physiology, chemistry, clinical studies) and multi-faceted (disease mechanisms, biology of cell death and survival, regeneration mechanisms, high-throughput screening, gene- and cell-based therapies) approach to this problem. Among the neurodegenerative diseases, we will focus on Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Spinal cord injury (SCI) will be the main model for neurotrauma. NeuroNE brings together investigators from different backgrounds (basic scientists, active clinicians and therapeutically-oriented SMEs) to work at all levels on a given disease: post-genomic science, molecular and cell biology, animal models, therapeutic strategies and clinical studies. Professional project management will provide efficient integration, realization of scientific objectives and knowledge management. Common infrastructures include shared NeuroNE-funded core facilities in 7 centres, while our web-based database will serve as a European depository for biological research tools. Training will be provided at several levels: by a competitive program of multi-centre postdoctoral fellowships, by mobility of NeuroNE scientists to other centres and platforms, and by the organization of summer schools and laboratory open days. To feed back the benefits of integration into EU society, we have involved patient organizations from the start, identified associated research groups who will benefit immediately from our infrastructures, and opened network meetings to identified scientists from emerging research centres.
Campo scientifico
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesclinical medicinetransplantation
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Parole chiave
Invito a presentare proposte
FP6-2003-LIFESCIHEALTH-I
Vedi altri progetti per questo bando
Meccanismo di finanziamento
NoE - Network of ExcellenceCoordinatore
CAMBRIDGE
Regno Unito
Mostra sulla mappa
Partecipanti (27)
LAUSANNE
Mostra sulla mappa
HEIDELBERG
Mostra sulla mappa
GOETTINGEN
Mostra sulla mappa
117 LUND
Mostra sulla mappa
BASEL
Mostra sulla mappa
MILANO
Mostra sulla mappa
HAIFA
Mostra sulla mappa
PARIS
Mostra sulla mappa
MUENCHEN
Mostra sulla mappa
STOCKHOLM
Mostra sulla mappa
GENEVA 4
Mostra sulla mappa
MARTINSRIED
Mostra sulla mappa
ULM
Mostra sulla mappa
LONDON
Mostra sulla mappa
ZWIJNAARDE
Mostra sulla mappa
MADRID
Mostra sulla mappa
ZURICH
Mostra sulla mappa
TORINO
Mostra sulla mappa
Case 931 MARSEILLE
Mostra sulla mappa
MADRID
Mostra sulla mappa
MARSEILLE
Mostra sulla mappa
COLOGNE
Mostra sulla mappa
PARIS
Mostra sulla mappa
PADOVA
Mostra sulla mappa
2313 REHOVOT
Mostra sulla mappa
CAMBRIDGE
Mostra sulla mappa
PARIS
Mostra sulla mappa